Mr. Dave Burwell reports

OCUMETICS ANNOUNCES ISSUANCE OF STOCK OPTIONS

Ocumetics Technology Corp. has issued 500,000 incentive stock options to Howard Group Inc., the corporation's investor relations communications adviser, as required by the agreement between the corporation and Howard Group announced on Sept. 12, 2025.

Each option entitles Howard Group to purchase one common share in the capital of the corporation at an exercise price per common share of 42 cents for a period of two years, which options shall vest quarterly in equal instalments over 12 months. The stock options are not transferable. The common shares issued upon exercise of the stock options will be subject to a four-month resale restriction from the date of grant.

About Ocumetics Technology Corp.

Ocumetics is a Canadian research and product development company that is dedicated to developing advanced vision correction solutions that enhance the quality of life for patients. Through innovative research and development, Ocumetics aims to transform the field of ophthalmology with state-of-the-art intraocular lenses and other vision-enhancing technologies.

Ocumetics is in the first-in-human early feasibility study phase of a game-changing technology for the ophthalmic industry. Ocumetics has developed an intraocular lens that fits within the natural lens compartment of the eye, potentially to eliminate the need for corrective lenses. It is designed to allow the eye's natural muscle activity to shift focus from distance to near, providing clear vision at all distances without the help of glasses or contact lenses.

We seek Safe Harbor.